Anti-obesity and Anti-fatty Liver Effects of Cynara scolymus L. Leaf Extract in Mice under Diet-induced Obesity
Eman M. Abd El Azeem, Barakat Alaa, Zeinab Zakaria
International Journal of Biochemistry Research & Review · pp. 1–11 · Published 3 Mar 2016
10.9734/IJBCRR/2016/23807Abstract
Objective: In this study, we conducted an animal study to investigate the effect of Cynara leaf extract (CLE) on visceral fat and serum lipid profile in animals fed on high fat diet (HFD). In addition, we focused on gene expression of some lipogenesis and lipolysis enzymes to investigate the anti-obesity and anti- fatty liver mechanism of CLE. Methods: Thirty male mice Swiss albino strain, at age of six weeks were classified into 3 groups. The first group was kept on standard normal diet and served as healthy control. Other animals received HFD for 4 weeks. These animals were assigned as HFD group and HFD + 5% Cynara scolymus leaf extract (CLE) -treated group. Results: CLE supplementation significantly reduced both body weight and white adipose tissue (WAT) weight with significant decrease in serum cholesterol, LDL- C and triacylglycerol. While serum HDL-C was significantly increased as compared to HFD group. Moreover, in the histological analysis, CLE improved fatty liver. Reverse transcription-polymerase chain reaction (RT-PCR) revealed that CLE up regulate the expression of mRNA of acetyl Co A (ACO) and hormone-sensitive lipase (HSL), in contrast, it suppressed the expression of fatty acid synthase (FAS) gene in the liver. While in WAT, the expressions of HSL gene was significantly upregulated at the main time FAS gene was down regulate when compared to HFD group. Conclusion: These results suggest that CLE exerts anti-obesity and anti-fatty liver effects in high-fat diet-induced obese mice through suppressing lipogenesis in the liver, stimulating lipolysis in WAT.
References (44)
- 1 Enzymatic Determination of Total Serum Cholesterol [DOI]
- 2 Theory and Practice of Histological Techniques
- 3 Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease [DOI]
- 4 Functional Brown Adipose Tissue in Healthy Adults [DOI]
- 5 Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. [DOI]
- 6 A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management [DOI]
- 7 The Journal of Steroid Biochemistry and Molecular Biology [DOI]
- 8 Long term maintenance of weight loss with non-surgical interventions in obese adults: systematic review and meta-analyses of randomised controlled trials [DOI]
- 9 Globe artichoke: A functional food and source of nutraceutical ingredients [DOI]
- 10 Hormone-sensitive lipase [DOI]
- 11 Anti-obesity effect of Nelumbo nucifera leaves extract in mice and rats [DOI]
- 12 Point: Visceral Adiposity Is Causally Related to Insulin Resistance [DOI]
- 13 Obesity and cancer [DOI]
- 14 Adiponectinemia in Visceral Obesity: Impact on Glucose Tolerance and Plasma Lipoprotein and Lipid Levels in Men [DOI]
- 15 Flavonoids Attenuate Cardiovascular Disease, Inhibit Phosphodiesterase, and Modulate Lipid Homeostasis in Adipose Tissue and Liver [DOI]
- 16 De novo lipogenesis in metabolic homeostasis: More friend than foe? [DOI]
- 17 Procoagulant imbalance in patients with non-alcoholic fatty liver disease [DOI]
- 18 The prevalence of nonalcoholic fatty liver disease in the Americas [DOI]
- 19 Reduction of lipid accumulation in HepG2 Cells by luteolin is associated with activation of AMPK and Mitigation of oxidative stress [DOI]
- 20 Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice [DOI]
- 21 Artichoke leaf extract (Cynara scolymus) reduces plasma cholesterol in otherwise healthy hypercholesterolemic adults: A randomized, double blind placebo controlled trial [DOI]
- 22 Nonalcoholic fatty liver disease and cardiovascular disease [DOI]
- 23 LDL-cholesterol determination in blood serum following precipitation of LDL with polyvinylsulfate [DOI]
- 24 Cholesterol synthesis is increased and absorption decreased in non-alcoholic fatty liver disease independent of obesity [DOI]
- 25 Systemic and Forearm Triglyceride Metabolism [DOI]
- 26 Inhibition of cholesterol biosynthesis in HepG2 cells by artichoke extracts is reinforced by glucosidase pretreatment [DOI]
- 27 Use of Complementary And Alternative Medicine for Weight Control in The United States [DOI]
- 28 Daidzein supplementation prevents non-alcoholic fatty liver disease through alternation of hepatic gene expression profiles and adipocyte metabolism [DOI]
- 29 Ursolic acid and luteolin‐7‐glucoside improve lipid profiles and increase liver glycogen content through glycogen synthase kinase‐3 [DOI]
- 30 Anti-obesity effects ofLysimachia foenum-graecumcharacterized by decreased adipogenesis and regulated lipid metabolism [DOI]
- 31 Nonalcoholic Fatty Liver Disease and Cardiovascular Disease [DOI]
- 32 Three-Dimensional Structure of the Flavoenzyme Acyl-CoA Oxidase-II from Rat Liver, the Peroxisomal Counterpart of Mitochondrial Acyl-CoA Dehydrogenase [DOI]
- 33 Genistein, a plant-derived isoflavone, counteracts the antilipolytic action of insulin in isolated rat adipocytes [DOI]
- 34 Obesity and Cancer [DOI]
- 35 Healthly properties of Jerusalem artichoke flour [Helianthus tuberosus L.]
- 36 The Crude Extract fromPuerariaeFlower Exerts Antiobesity and Antifatty Liver Effects in High-Fat Diet-Induced Obese Mice [DOI]
- 37 CYNARA SCOLYMUS FOR RELIEVING ON NONALCOHOLIC STEATOHEPATITIS INDUCED IN RATS
- 38 Anti-obesity and hypolipidemic effects of a functional formula containing Prumus mume in mice fed high-fat diet [DOI]
- 39 Modulatory Effects of Artichock Leave Extract on Nandrolone Decanoate-Induced Biochemical Alterations in Rats
- 40 Liver ultrasound scanning in the detection of hepatic steatosis and fibrosis in NASH patients [DOI]
- 41 Procoagulant imbalance in patients with non-alcoholic fatty liver disease [DOI]
- 42 Hepatic Catabolism of Remnant Lipoproteins: Where the Action Is [DOI]
- 43 Is Visceral Fat Responsible for the Metabolic Abnormalities Associated With Obesity? [DOI]
- 44 Another Agent for Obesity — Will This Time Be Different? [DOI]
Cited by 12
Manisha Thakur, Neeru Vasudeva, Sunil Sharma · CNS & Neurological Disorders - Drug Targets · 2023
Selen Ilgün · Novel Drug Targets With Traditional Herbal Medicines · 2022
Manjusha Choudhary, Sakshi Sharma, Sunishtha Kalra · Current Traditional Medicine · 2023
Wiraphol Phimarn, Bunleu Sungthong, Kittisak Wichiyo · Pharmacognosy Magazine · 2024
Mohaddese Mahboubi · Bulletin of Faculty of Pharmacy, Cairo University · 2018
Noureddine Bencheikh, Amine Elbouzidi, Abdellah Baraich · Frontiers in Pharmacology · 2024
Showing 6 of 12 known citations — external sources report more than can currently be individually listed.
Related research
Article metrics
Real usage data collected on this platform.
16
Page views
0
PDF downloads
13
Outbound clicks
12
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.